Skip to main content
Premium Trial:

Request an Annual Quote

Raynard Kington, Elias Zerhouni, Michael Berens, MaryAnn Guerra

Premium
Raynard Kington has become acting director of the National Institutes of Health, following the departure of Elias Zerhouni on Oct. 31. Kington has taken over the post until a new director is appointed after the US presidential elections. He has served as Zerhouni’s deputy since 2003. Prior to that, he was associate director of NIH for behavioral and social sciences research.
 

 
The Arizona Technology Council has appointed Michael Berens and MaryAnn Guerra of the Translational Genomics Research Institute to its board of directors. Berens, who was appointed chairman emeritus of the board, is the director of the cancer and cell biology division at TGen. Guerra is TGen’s chief business officer.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.